China Bans Messaging App Signal; Pfizer to Halt Biosimilar Drug Production in China

Another private messaging app is banned in China. The U.S.-based app Signal encrypts users’ conversations.

American drugmaker Pfizer reveals plans to stop producing biosimilar products in China.

ntd newsletter icon
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
By registering for the newsletter, you agree to the Privacy Policy.